The Impact of Cost Cutting on MD-PhD Programs in Canada: Equity, Diversity, and Inclusion Challenges for Clinician-Scientist Training Programs.

IF 0.8 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Anna Frumkin, Grace Yu, Kaiyang Li, Mimosa Luigi, Jamie Magrill
{"title":"The Impact of Cost Cutting on MD-PhD Programs in Canada: Equity, Diversity, and Inclusion Challenges for Clinician-Scientist Training Programs.","authors":"Anna Frumkin, Grace Yu, Kaiyang Li, Mimosa Luigi, Jamie Magrill","doi":"10.3138/cim-2025-0072","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>MD-PhD programs play a critical role in training the next generation of clinician-scientists in Canada. However, since 2015, these programs have faced increasing financial pressures. This review examines the impact of cost-cutting measures on Canadian MD-PhD programs and their implications for equity, diversity, and inclusion initiatives in the Canadian context.</p><p><strong>Methods: </strong>Using a mixed-methods approach, we analyzed funding structures across all 11 Canadian MD-PhD programs and compared them with 120 U.S. MD-PhD programs using publicly available data.</p><p><strong>Results: </strong>Eighteen percent of Canadian MD-PhD programs (2 of 11) offer full funding, compared to 43% (52 of 120) of U.S. programs. Canadian MD-PhD applicants from two provinces (British Columbia and Ontario) have access to fully funded in-catchment programs (49% of Canada's population). By contrast, U.S. MD-PhD applicants from 31 states have access to fully funded in-catchment programs through Medical Scientist Training Programs (MSTPs) (85% of the U.S. population). Canadian MD-PhD programs have a more uneven geographical distribution and funding landscape than those in the United States, limiting accessibility for Canadian students from underrepresented and lower socioeconomic backgrounds.</p><p><strong>Conclusions: </strong>Despite recent increases in diversity among MD-PhD trainees, financial constraints threaten to reverse these gains, reducing opportunities for historically marginalized groups. This review highlights the need for renewed provincial and federal investment in MD-PhD training. Without targeted policy and funding supports, the sustainability of Canadian MD-PhD programs-and the future of Canada's clinician-scientist training pipeline-remains uncertain. Addressing these challenges is essential to maintaining Canada's global competitiveness in medical and scientific innovation and ensuring that clinician-scientist leadership reflects the diversity of the patient populations they serve.</p>","PeriodicalId":50683,"journal":{"name":"Clinical and Investigative Medicine","volume":"48 2","pages":"38-46"},"PeriodicalIF":0.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Investigative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3138/cim-2025-0072","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: MD-PhD programs play a critical role in training the next generation of clinician-scientists in Canada. However, since 2015, these programs have faced increasing financial pressures. This review examines the impact of cost-cutting measures on Canadian MD-PhD programs and their implications for equity, diversity, and inclusion initiatives in the Canadian context.

Methods: Using a mixed-methods approach, we analyzed funding structures across all 11 Canadian MD-PhD programs and compared them with 120 U.S. MD-PhD programs using publicly available data.

Results: Eighteen percent of Canadian MD-PhD programs (2 of 11) offer full funding, compared to 43% (52 of 120) of U.S. programs. Canadian MD-PhD applicants from two provinces (British Columbia and Ontario) have access to fully funded in-catchment programs (49% of Canada's population). By contrast, U.S. MD-PhD applicants from 31 states have access to fully funded in-catchment programs through Medical Scientist Training Programs (MSTPs) (85% of the U.S. population). Canadian MD-PhD programs have a more uneven geographical distribution and funding landscape than those in the United States, limiting accessibility for Canadian students from underrepresented and lower socioeconomic backgrounds.

Conclusions: Despite recent increases in diversity among MD-PhD trainees, financial constraints threaten to reverse these gains, reducing opportunities for historically marginalized groups. This review highlights the need for renewed provincial and federal investment in MD-PhD training. Without targeted policy and funding supports, the sustainability of Canadian MD-PhD programs-and the future of Canada's clinician-scientist training pipeline-remains uncertain. Addressing these challenges is essential to maintaining Canada's global competitiveness in medical and scientific innovation and ensuring that clinician-scientist leadership reflects the diversity of the patient populations they serve.

成本削减对加拿大医学博士项目的影响:临床医生-科学家培训项目的公平性、多样性和包容性挑战。
背景:医学博士课程在加拿大培养下一代临床科学家方面起着至关重要的作用。然而,自2015年以来,这些项目面临着越来越大的财政压力。这篇综述考察了削减成本措施对加拿大医学博士项目的影响,以及它们对加拿大背景下的公平、多样性和包容性倡议的影响。方法:采用混合方法,我们分析了所有11个加拿大医学博士学位项目的资助结构,并使用公开数据将其与120个美国医学博士学位项目进行了比较。结果:18%的加拿大医学博士项目(11个项目中有2个)提供全额资助,而美国的这一比例为43%(120个项目中有52个)。来自两个省(不列颠哥伦比亚省和安大略省)的加拿大医学博士申请人可以获得全额资助的集水区项目(占加拿大人口的49%)。相比之下,来自31个州的美国医学博士申请人可以通过医学科学家培训计划(mstp)获得全额资助的流域项目(占美国人口的85%)。与美国相比,加拿大医学博士课程的地理分布和资金状况更加不平衡,这限制了来自代表性不足和社会经济背景较低的加拿大学生的入学机会。结论:尽管最近医学博士受训者的多样性有所增加,但财政限制可能会逆转这些成果,减少历史上边缘化群体的机会。这篇综述强调了重新增加省级和联邦对医学博士培训的投资的必要性。没有针对性的政策和资金支持,加拿大医学博士项目的可持续性以及加拿大临床医生-科学家培训管道的未来仍然不确定。应对这些挑战对于保持加拿大在医疗和科学创新方面的全球竞争力和确保临床医生-科学家的领导能力反映他们所服务的患者群体的多样性至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Investigative Medicine
Clinical and Investigative Medicine 医学-医学:研究与实验
CiteScore
1.50
自引率
12.50%
发文量
18
审稿时长
>12 weeks
期刊介绍: Clinical and Investigative Medicine (CIM), publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信